Intel’s first discrete Arc desktop GPUs are coming in Q2 2022

 Unveiled today, Intel’s first discrete desktop GPUs, known as Xe-HPGD (high performance 128 EUs), are scheduled to launch in the second quarter of 2022. The game-changing GPUs will redefine the graphics and compute capabilities of the data center by delivering on the promise of extreme compute-on-demand.

Intel has been publicly discussing its Xe graphics architecture for years, but it has so far resisted the urge to make an entire GPU silicon package. Now, Intel has announced that a discrete Xe-based GPU will debut in Q2 2022. If you’re wondering why adding GPUs doesn’t sound like something “new,” it’s because this announcement is mostly a confirmation of what we already knew.

Intel is about to launch its first discrete graphics processing unit – it's called Xe-HPG. The chipmaker said that the GPU will target gamers and professionals, delivering powerful graphics performance. According to Intel's principal engineer, Raja Koduri, the Xe-HP graphics chips are coming in Q2 2022 and will be powered by the next-gen Gen12 architecture.

Intel announced today that it’ll ship its first discrete GPU for desktop PCs — a.k.a, the first one to include its own memory and not share main memory with the CPU — in Q2 2022, two years later than planned. It’s still hoping to launch its Xe-HPG (high-performance graphics) GPU line for desktop workstations this year, though it hasn’t announced a release date. Xe-HPC (high-performance computing) GPUs are set for 2023, as well as the launch of Intel’s in-house Foveros 3D packaging technology that should allow for even better performance and lower power consumption

Comments

Post a Comment

Popular posts from this blog

An insulin patch that sticks inside a person’s cheek

  A new insulin patch aims to help people with diabetes eliminate injections by sticking inside their cheek. The only catch: It won’t be available for a few years and humans must first test it out on the backs of pigs. Medics develop insulin patch that sticks inside a person's cheek. Able to deliver blood-sugar lowering drug for up to 16 hours, no jabbing required.' This insulin patch sticks inside a person’s cheek so doesn’t require the frequent injections of traditional insulin treatments . The patch works especially well for diabetics who want to avoid constant needle pricks, and would also allow them not to have to carry around syringes or frequently reach for drugs when they’re out and about. For diabetics , we now have insulin patches that stick inside the cheek. Each patch contains hundreds of tiny needles, which reach under the skin and release a measured dose into the bloodstream . Unlike traditional injections, this patch sticks inside your cheek and allows...
Read more

Google and Mozilla are ready for Chrome and Firefox version 100 to break some websites

 Google and Mozilla engineers have already planned for Chrome and Firefox version 100 to break some web sites, with both companies saying that it's time to clean up the mess that's been made. Chrome 89, which ships in early March, will remove support for the "window.showModalDialog" DOM API, which is an ancient piece of code from 1998 that conflicts with Web standards and exists only for compatibility with Microsoft's aging Internet Explorer browser.  The next time you see a badly broken website, you might just have to send an angry email to its webmaster . With the release of Chrome 100 and Firefox 93 on Tuesday, Google and Mozilla are removing features from their browsers that some websites still use to hide text from visitors. This means when those sites haven’t updated their code , they will show the “hidden” content — usually because the site ignored their visitor's requests for a more accessible design. Looks like Chrome and Firefox are just around a ma...
Read more

Breast Cancer Kyu Hota Hai

 Breast cancer is a global health issue that can no longer be ignored. Substantial support for breast cancer awareness and research funding has helped created advances in the diagnosis and treatment of breast cancer. Breast cancer survival rates have increased, and the number of deaths associated with this disease is steadily declining, largely due to factors such as earlier detection, a new personalized approach to treatment and a better understanding of the disease. This year, many people will be diagnosed with breast cancer. The good news is that advances like earlier detection, new treatment and a better understanding of the disease, have helped survival rates improve tremendously over the past few decades.  The American Cancer Society is attacking breast cancer from every angle. We're funding groundbreaking research and fighting for federal policies that help protect people from the disease, helping people get well through support and services, speaking out on importan...
Read more